Tetrahydrophthalimide (THPI) is a cyclic imide derived from phthalic anhydride. It is a white crystalline solid with a melting point of 145-148 °C. THPI is used as a monomer in the production of polymers, such as polyimides and polyamides. It is also used as an intermediate in the synthesis of other organic compounds. THPI is a versatile chemical with a wide range of applications, including in the fields of pharmaceuticals, agriculture, and materials science. It is also used as a catalyst in various organic reactions. THPI is a potential candidate for use in the production of novel materials with enhanced properties.'
tetrahydrophthalimide: captan metabolite in fruit crops
ID Source | ID |
---|---|
PubMed CID | 6808 |
CHEMBL ID | 3187796 |
SCHEMBL ID | 1568506 |
MeSH ID | M0054106 |
Synonym |
---|
1h-isoindole-1,3(2h)-dione, 3a,4,7,7a-tetrahydro- |
3a,4,7,7a-tetrahydro-1h-isoindole-1,3(2h)-dione |
ccris 3648 |
nsc 59011 |
brn 0128764 |
hsdb 5006 |
isoindole-1,3-dione, 3a,4,7,7a-tetrahydro- |
1h-isoindole-1,3(2h)-dione, 3-alpha,4,7,7-alpha-tetrahydro- |
einecs 201-602-8 |
delta(sup 4)-tetrahydrophthalimide |
delta(4)-tetrahydrophthalimide |
tetrahydrophthalimide (van) |
1,2,3,6-tetrahydrophthalimide |
isoindole-1, 3a,4,7,7a-tetrahydro- |
nsc59011 |
1,3,6-tetrahydrophthalimide |
.delta.4-tetrahydrophthalimide |
nsc-59011 |
tetrahydrophthalic acid imide |
85-40-5 |
1h-isoindole-1, 3a,4,7,7a-tetrahydro- |
4-cyclohexene-1,2-dicarboximide |
tetrahydrophthalimide |
3a,4,7,7a-tetrahydroisoindole-1,3-dione |
FT-0655614 |
inchi=1/c8h9no2/c10-7-5-3-1-2-4-6(5)8(11)9-7/h1-2,5-6h,3-4h2,(h,9,10,11) |
ciffbtojcksrjy-uhfffaoysa- |
HMS1722F15 |
AKOS001040878 |
NCGC00248318-01 |
ec 201-602-8 |
5-21-10-00130 (beilstein handbook reference) |
STK724078 |
dtxcid106513 |
tox21_301178 |
dtxsid8026513 , |
cas-85-40-5 |
NCGC00255076-01 |
1,2,3,6-tetrahydrophthalimide, 4-cyclohexene-1,2-dicarboximide, thpi |
FT-0675043 |
AKOS025243539 |
SCHEMBL1568506 |
AKOS016842521 |
1,2,3,6-tetrahydrophtalimide |
3a,4,7,7a-tetrahydro-1h-isoindole-1,3(2h)-dione # |
W-104083 |
1,2,3,6-tetrahydro phthalimide |
FD14008 |
CHEMBL3187796 |
3alpha,4,7,7alpha-tetrahydro-1h-isoindole-1,3(2h)-dione |
2,3,3a,4,7,7a-hexahydro-1h-isoindole-1,3-dione |
mfcd00042782 |
mfcd00005880 |
3-hydroxy-3a,4,7,7a-tetrahydro-1h-isoindol-1-one |
AC-8837 |
tetrahydrophthalimid |
3a,4,7,7a-tetrahydro-cis-1h-isoindole-1,3(2h)-dione |
3-alpha,4,7,7-alpha-tetrahydro-1h-isoindole-1,3(2h)-dione |
3a,4,7,7a-tetrahydro-isoindole-1,3-dione |
laquo deltaraquo 4-tetrahydrophthalimide |
1,2,5,6-tetrahydrophthalimide |
SY003867 |
CS-0077658 |
FT-0739667 |
Q21045269 |
AMY10828 |
EN300-05179 |
SB66392 |
SY102061 |
Z56893117 |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
progesterone receptor | Homo sapiens (human) | Potency | 0.2434 | 0.0004 | 17.9460 | 75.1148 | AID1346795 |
retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 54.4827 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 2.7306 | 0.0016 | 28.0151 | 77.1139 | AID1259385 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 6 (28.57) | 18.7374 |
1990's | 3 (14.29) | 18.2507 |
2000's | 1 (4.76) | 29.6817 |
2010's | 11 (52.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (32.70) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (7.69%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 1 (3.85%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 23 (88.46%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |